Pierre A MORGON
MRGN Advisors, Switzerland
Scientific Tracks Abstracts: J Vaccines Vaccin
Pierre A MORGON is Chief Executive Officer of MRGN Advisors, a consultancy dedicated to the healthcare sector, and Regional Partner for Switzerland at Mérieux Développement, an evergreen investment structure focused on medical devices, in vitro diagnostics and patient management services. He is also Chairman of the Board of Virometix (developing proprietary synthetic nanoparticle platform in vaccines and immunotherapeutic drugs for viral diseases and cancer), Non- Executive Director to the Board of Theradiag (focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy) and Non-Executive Director to the Board of Eurocine Vaccines (developing intra nasal vaccines). He holds a Doctorate of Pharmacy, Master degree in Business Law and MBA.